Inhibition of Cyclooxygenase-2 (COX-2) Initiates Autophagy and Potentiates MPTP-Induced Autophagic Cell Death of Human Neuroblastoma Cells, SH-SY5Y: an Inside in the Pathology of Parkinson's Disease

Molecular Neurobiology
Rituraj NiranjanAshwani Kumar Thakur

Abstract

Cyclooxygenase-2 or COX-2 has been known to be crucial for Parkinson's disease (PD) pathogenesis; however, its exact role is still not known. We first time report that inhibition of COX-2 promotes 1-methyl-4-phenyl 1,2,3,6 tetrahydropyridine (MPTP)-induced neuronal cell death via induction of autophagic mechanisms. We found that treatment with MPTP induced cell death of neuroblastoma cells SH-SY5Y in a dose dependent manner. Treatment of MPTP has also upregulated the expressions of autophagic proteins such as LC3, beclin, ATG-5, and p62. Interestingly, nimesulide, a preferential COX-2 inhibitor, further potentiated the MPTP-induced cell death of human neuroblastoma cells. Treatment of nimesulide with MPTP further potentiated expressions of p62, ATG-5, beclin-1, LC3 autophagic proteins. Furthermore, nimesulide with MPTP increased apoptotic protein cleaved caspase-3 and also induced expression of p53 gene. Interestingly, it was observed that Akt inhibitor significantly increased MPTP-induced cell death of neuroblastoma cells. However, (-) deprenyl, a monoamine oxidase B (MAO B) inhibitor, attenuated MPTP-induced autophagic response and protected cell death. The prior treatment with prostaglandin E2 protected against nimesulide in...Continue Reading

References

Apr 1, 2003·Annals of Neurology·Stephane Hunot, E C Hirsch
Sep 30, 2004·Journal of Neuropathology and Experimental Neurology·Luisa Minghetti
Mar 18, 2006·Apoptosis : an International Journal on Programmed Cell Death·V D Nair
Apr 19, 2006·Annals of Neurology·Gabriele AlmerSerge Przedborski
May 31, 2006·Neurochemical Research·Tirupapuliyur V DamodaranMohamed B Abou-Donia
Aug 26, 2006·Trends in Molecular Medicine·Ana Maria Cuervo
Oct 13, 2006·Autophagy·Faisal AdhamiChia-Yi Kuan
Oct 25, 2006·The Journal of Biological Chemistry·Venugopalan D NairC Warren Olanow
Jan 2, 2007·Neuroscience Letters·Makio MogiToshiharu Nagatsu
Jun 19, 2007·Neuroscience Letters·Liejun WuKatrin Andreasson
Jul 17, 2007·Neurochemistry International·Takako TakemiyaKanato Yamagata
Jul 25, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Hui-Ming GaoVirginia M-Y Lee
Aug 9, 2008·The American Journal of Pathology·Dun-Sheng YangRalph A Nixon
Mar 20, 2009·Lancet Neurology·Etienne C Hirsch, Stéphane Hunot
Oct 8, 2009·Prostaglandins & Other Lipid Mediators·Katrin Andreasson
Nov 10, 2009·Journal of Neurochemistry·Christopher M DavenportJennifer M Pocock
Nov 18, 2009·Molecular Neurodegeneration·Tamy C Frank-CannonMalú G Tansey
Mar 2, 2010·Seminars in Cell & Developmental Biology·Moisés García-ArencibiaDavid C Rubinsztein
Mar 13, 2010·The Journal of Pathology·Danielle GlickKay F Macleod
Sep 3, 2010·Current Neuropharmacology·Anna L Bartels, Klaus L Leenders
Oct 26, 2011·Molecular Pain·Laura BerliocchiMaria Tiziana Corasaniti
Nov 15, 2011·Experimental and Molecular Pathology·William H HoffmanAnuska V Andjelkovic
Jan 31, 2012·Experimental Neurology·Robert E Burke, Karen O'Malley
Nov 6, 2012·Progress in Neuro-psychopharmacology & Biological Psychiatry·Kyoung-Sae NaYong-Ku Kim
Feb 5, 2013·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Fabio Blandini
Apr 13, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Benjamin DehayErwan Bezard
Sep 10, 2013·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Rituraj NiranjanRakesh Shukla
Nov 23, 2013·International Immunopharmacology·Daniela S ArroyoPablo Iribarren
Dec 25, 2013·Handbook of Clinical Neurology·Eitan AurielAmos D Korczyn
Jan 15, 2014·Biochimica Et Biophysica Acta·Rosanna Parlato, Birgit Liss

❮ Previous
Next ❯

Citations

Apr 13, 2019·Current Topics in Medicinal Chemistry·Niraj Kumar JhaRituraj Niranjan
Jan 14, 2020·Evidence-based Complementary and Alternative Medicine : ECAM·Renrong WeiTongxiang Lin
Jul 2, 2020·Cancer Management and Research·Xiangjie FuPeijun Liu
Sep 16, 2021·Journal of Mass Spectrometry : JMS·Junjie ZhangChun Cai

❮ Previous
Next ❯

Methods Mentioned

BETA
Assay
X-ray

Software Mentioned

GraphPad prism

Related Concepts

Related Feeds

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Parkinson's Disease & Autophagy

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.